The immuno-oncology and antibody–drug conjugates (ADCs) market represents one of the most dynamic and rapidly advancing segments of the global oncology therapeutics industry. Immuno-oncology focuses on harnessing the body’s immune system to recognize, target, and eliminate cancer cells, while ADCs combine the specificity of monoclonal antibodies with the potent cell-killing ability of... https://www.databridgemarketresearch.com/reports/global-immuno-oncology-and-adcs-market